Candida oesophagitis with hepatitis C virus: An uncommon association

European Journal of Gastroenterology and Hepatology

Volumn 15, Issue 6, 2003, Pages 701-703

  Yakoob, Javed ^a   Jafri, Wasim ^a   Hussainy, Akbar S ^a  

^a AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

Author keywords

Candida oesophagitis; Hepatitis C virus; Immunosuppression

Indexed keywords

ALANINE AMINOTRANSFERASE; AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HEPATITIS C ANTIBODY; INTERFERON; NYSTATIN; OMEPRAZOLE; RIBAVIRIN;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ANAMNESIS; ANOREXIA; ARTICLE; CANDIDA; CASE REPORT; CHRONIC HEPATITIS; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; ESOPHAGITIS; ESOPHAGUS BIOPSY; FEMALE; GASTROINTESTINAL ENDOSCOPY; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNE DEFICIENCY; LABORATORY TEST; LIVER BIOPSY; POLYMERASE CHAIN REACTION; PORTAL VEIN; PRIORITY JOURNAL; SERODIAGNOSIS; SUPERINFECTION; UPPER GASTROINTESTINAL TRACT;

ADULT; CANDIDIASIS; ESOPHAGITIS; FEMALE; HEPATITIS C, CHRONIC; HUMANS; OPPORTUNISTIC INFECTIONS;

EID: 0038120877     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200306000-00019     Document Type: Article

References (11)

1. Holmberg SD, Buchbinder SP, Conley LJ, Wong LC, Katz MH, Penley KA, et al. The spectrum of medical conditions and symptoms before AIDS in homosexual and bisexual men infected with the HIV. Am J Epidemiol 1995; 141:395-406.
2. Bonacini M, Young T, Laine L. The causes of esophageal symptoms in human immunodeficiency virus infection. A prospective study of 110 patients. Arch Intern Med 1991; 151:1567-1572.
3. Shah HA, Jafri W, Malik I, Prescott L, Simmonds P. HCV genotypes and chronic liver disease in Pakistan. J Gastroenterol Hepatol 1997; 12:758-761.
4. Missale G, Bertoni R, Lamonaca V, Valli A, Massari M, Mori C, et al. Different clinical behaviors of acute HCV infection are associated with different vigor of the anti-viral cell-mediated immune response. J Clin Invest 1996; 98:706-714.
5. Yao ZQ, Nguyen DT, Hiotellis AI, Hahn YS. HCV core protein inhibits human T lymphocyte responses by a complement-dependent regulatory pathway. J Immunol 2001; 167:5264-5272.
6. Crovatto M, Pozzato G, Zorat F, Pussini E, Nascimben F, Baracetti S, et al. Peripheral blood neutrophils from HCV-infected patients are replication sites of the virus. Haematologica 2000; 85:356-361.
7. Mazzaro C, Panarello G, Tesio F, Santini G, Crovatto M, Mazzi G, et al. HCV risk: a HCV related syndrome. J Intern Med 2000; 247:535-545.
8. Jirillo E, Greco B, Caradonna L, Satalino R, Pugliese V, Cozzolongo R, et al. Evaluation of cellular immune responses and soluble mediators in patients with cHCV infection. Immunopharmacol Immunotoxicol 1995; 17:347-364.
9. Jirillo E, Greco B, Caradonna L, Satalino R, Amati L, Cozzolongo R, et al. Immunological effects following administration of interferon-alpha in patients with cHCV infection. Immunopharmacol Immunotoxicol 1996; 18:355-374.
10. Cuthbert JA. Hepatitis C: progress and problems. Clin Microbiol Rev 1994; 7:505-532.
11. Kanto T, Hayashi N, Takehara T, Tatsumi T, Kuzushita N, Ito A, et al. Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from HCV-infected individuals. J Immunol 1999; 162:5584-5591.